Back to School: How biopharma can reboot drug development. Access exclusive analysis here
BAY will temporarily suspend worldwide marketing of Trasylol aprotinin at the request of regulatory agencies in
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury